Project Number GC-2012811 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Treatment strategies based on enhancing dopamine release from noradrenergic axons. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator Lisman, John Principal Investigator First Name John Principal Investigator Last Name Lisman Awardee Organization BRANDEIS UNIVERSITY Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $461,910 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
